# Cedars-Sinai

Type: Company

Source: Healthcare Intelligence Brief — https://gethealthbrief.com/entity/cedars-sinai
Canonical HTML page: https://gethealthbrief.com/entity/cedars-sinai

## Timeline

- **2026-09-09**: Q2 earnings call — Nano-X management presents second-quarter results, emphasizing cost cuts, distributor expansion, and early imaging network economics.
- **2026-06-30**: Second quarter ends — Nano-X's fiscal second quarter closes with revenue of $4.2 million and a $40.7 million impairment charge.
- **2026-04-01**: Medicare CAC analysis code effective — A new Medicare code covering algorithmic analysis of coronary artery calcium takes effect, opening reimbursement for Nano-X's cardiac AI tool.
- **2025-11-19**: Nano-X acquires Nanox Health IT — Nano-X Imaging completes the acquisition of Nanox Health IT, later consolidated into Q2 2026 results.

## Recent coverage (1 stories)

### Nano-X Cardiac AI Hits 92% Accuracy; First Site Billing $200-$700 per Scan
2026-09-13 17:33:11 · Sentiment: Neutral · Impact: 5/10 · Sources: 2

Nano-X's Q2 shows teleradiology growing 14%, but the clinical story is the cardiac AI validated at Cedars-Sinai and the first Philadelphia imaging site billing $200-$700 per scan. The Medicare coronary artery calcium code effective April 1 creates a reimbursement path.
Full story: https://gethealthbrief.com/story/nano-x-cardiac-ai-cedars-sinai-imaging-network

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://gethealthbrief.com/guides/methodology for the full editorial methodology.